Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
暂无分享，去创建一个
J. Carulli | M. McKeown | M. Eaton | P. Fenaux | T. Cluzeau | S. de Botton | J. Liesveld | M. Sekeres | C. Fiore | P. Rousselot | D. Rizzieri | G. Roboz | T. Braun | D. Bixby | J. Jurcic | E. Stein | G. Hodgson | A. Banos | M. Savona | C. Vigil | R. Cook | Kate Madigan | A. Volkert | M. Kelly | K. Stephens | Q. Kang-Fortner | D. Roth | K. Baker | Sofia Paul